Who is the sponsor?
National Eye Institute (NEI)
Who are the patients?
Patients 18 years of age and older with type 1 or type 2 diabetes and macular edema. The participating doctor will evaluate you to determine your eligibility into the study in accordance with the Study Eligibility and Exclusion Criteria.
How long are the eligible patients enrollment?
All patients will return for follow-up visits at 3, 6, and 12 months. After the first year, patients will be followed every 6 months until either the patient returns for a 3-year visit or the last enrolled patient returns for the 1-year visit.
When did participation agreement start at our site?
What is the enrollment goal for the sponsor?
One hundred nationwide.
Is the enrollment still open?
No. This study is now closed
What is this study investigating?
This study will compare two types of laser treatments for diabetic macular edema, a common condition in patients with diabetes. This study will also examine whether celecoxib (Celebrex®), an anti-arthritis drug that reduces inflammation and swelling, can reduce inflammation and swelling of the retina.
How is the treatment administered?
Laser therapy and Drug therapy (celecoxib).